🧬 BioMed Pulse · 2026-11-04 02:01 UTC

BIOMED PULSE

Wednesday, November 4, 2026 — Daily Briefing on Longevity, Viruses & New Cures

⚡ TL;DR

The Bundibugyo virus (Ebola-family) outbreak in the Democratic Republic of the Congo has now spread to Kenya and Nigeria, making it the largest Ebola outbreak ever recorded — over 1,460+ confirmed cases and growing across six DRC provinces plus imported cases abroad. [1]

Mood: Urgent on outbreak containment; cautious optimism in longevity science as sarcopenia and senolytic research post new findings.

🦠 OUTBREAKS & VIRUSES

BUNDIBUGYO VIRUS DISEASE (EBOLA-FAMILY) — DRC, KENYA, NIGERIA

  • As of October 23, 2026, WHO's DON-622 confirms Bundibugyo virus disease (BVD) has spread beyond DRC to Kenya and Nigeria via imported cases, with sustained high-level transmission in DRC. [1]
  • The outbreak first declared on May 15, 2026 in DRC and Uganda; by July 1 it had reached 1,460 confirmed cases and 452 deaths in DRC alone, then accelerated to 2,124 confirmed cases and 828 deaths by July 15. [2] [3]
  • By August 14, WHO called it the largest Ebola outbreak ever reported in DRC, expanding faster than any previous Ebola outbreak across 6 provinces: Bas-Uele, Haut-Uele, Ituri, North Kivu, South Kivu, and Tshopo. [4]
  • By September 25, a seventh province — Sud Ubangi in northwest DRC — was confirmed affected, marking further westward geographic spread. [5]
  • An imported confirmed BVD case in Kenya was reported to WHO on October 5, 2026, in a patient who transited through Uganda from DRC; hospitalized in stable condition. [6]
  • Enhanced Ebola airport screening has been operating at Washington-Dulles and Atlanta international airports since late May 2026 in response to this outbreak. [7] [8]

MERS-COV — SAUDI ARABIA

  • Between January 1 and October 5, 2026, Saudi Arabia reported 8 laboratory-confirmed MERS-CoV cases including 1 death, detected in 6 locations: Al Jouf, Arar, Hafr Al-Batin, Riyadh (2 cases), and Tabuk. [9]

PNEUMONIA OF UNDETERMINED ETIOLOGY — RUSSIA

  • On October 2, 2026, WHO became aware via media of the death of a Irkutsk Antiplague Research Institute (APRI) employee in Siberia, Russia, following hospitalization for severe pneumonia; cause remains undetermined. [10]

ANDES HANTAVIRUS — CRUISE SHIP (MULTI-LOCATION)

  • WHO's fifth DON on the Andes hantavirus (ANDV) outbreak linked to the M/V Hondius cruise ship confirmed ongoing multi-location spread as of July 2, 2026, with cases traced to the initial notification of severe acute respiratory illness aboard the vessel on May 2, 2026.

NIPAH VIRUS — INDIA

  • On June 11, 2026, Kerala State Health Department confirmed one laboratory-confirmed Nipah virus (NiV) case in a male patient in Kozhikode district who developed neurological symptoms on May 30 and was hospitalized June 10.

YELLOW FEVER — GLOBAL

  • From January 1 to May 26, 2026, six countries reported 79 human yellow fever infections, following elevated transmission in the Americas throughout 2025 that continued into 2026.

DRUG-RESISTANT BACTERIA — U.S.

  • A September 2025 CDC report documented a dramatic rise in dangerous drug-resistant bacteria in the United States; no specific pathogen count disclosed in the summary.

🧬 LONGEVITY & AGING

GDF11 AND MUSCLE AGING (SARCOPENIA)

  • A new study published in Genes & Disease shows growth differentiation factor 11 (GDF11) restores skeletal muscle satellite cell function via the MYC transcription factor pathway, directly counteracting age-related muscle wasting (sarcopenia) in animal models.
  • Satellite cells are the stem cells that repair and regenerate muscle fibers; their decline with age is a primary driver of the sarcopenia that robs older adults of strength and independence.

MTORC1 INHIBITION AND DISC DEGENERATION

  • Researchers (Hiranaka, Yurube et al.) published in Bioactive Materials that cationized gelatin nanospheres delivering RNA interference targeting mTORC1 (a central aging-related nutrient sensor and longevity pathway) significantly protected against intervertebral disc degeneration in preclinical models.
  • mTORC1 suppression is a well-established longevity mechanism; this study presents a controlled-release nanosphere delivery route that could translate to human disc disease.

STATIN DISCONTINUATION AND FRAILTY IN OLDER ADULTS

  • A large population-wide retrospective cohort study in England using Clinical Practice Research Datalink data (Seeley, van der Veen et al., Lancet Healthy Longevity) examined the efficacy and safety of stopping statins in patients aged 65 and older, stratified by frailty status.
  • An accompanying editorial by Bardoczi and Rodondi asks whether frailty should guide statin discontinuation decisions — a clinically pressing question as polypharmacy is a key driver of adverse outcomes in older adults.

AI FACE-PHOTO BIOLOGICAL AGE CLOCK

  • The FAHR-Face model (Haugg, Lee, He et al., Lancet Digital Health) uses foundation AI trained on facial photographs to estimate biological age and health risk, validated across multiple cohorts; corresponding author includes longevity researcher Vadim Gladyshev of Harvard.
  • A separate Lancet Digital Health study (Joy, Punjabi et al.) showed AI cardiac MRI segmentation of the left ventricle outperformed clinicians in predicting all-cause mortality in a retrospective multicentre prognostic study, reinforcing AI's role in longevity-relevant cardiovascular risk assessment.

SENOLYTIC POTENTIAL OF METFORMIN IN COPD

  • A registered ClinicalTrials.gov study (NCT07275359) is actively investigating metformin's senolytic properties and its effect on blood biomarkers of cellular aging in COPD patients without diabetes, alongside pulmonary rehabilitation.
  • Senolytics are drugs that clear out dysfunctional "zombie" (senescent) cells that accumulate with age and drive chronic inflammation — metformin is being tested as an affordable, existing drug that may serve this function.

PET AMYLOID IMAGING IN THE BALTIMORE LONGITUDINAL STUDY OF AGING

  • Trial NCT07099053 is enrolling participants in the Baltimore Longitudinal Study of Aging to track amyloid protein accumulation in the brain using PET imaging as people age, aiming to identify early cognitive decline biomarkers.

OLDER ADULTS IN HUMANITARIAN CRISES — A LONGEVITY EQUITY GAP

  • A Lancet Healthy Longevity series (multiple authors, 2026-2027 preprints) flags that older adults are systematically overlooked in humanitarian emergencies, facing gaps in sexual and reproductive health, palliative care, malnutrition screening, and person-centred care frameworks.

💊 NEW CURES & APPROVALS

RIVAROXABAN GENERIC — TEVA PHARMACEUTICALS USA

  • Teva Pharmaceuticals USA received an original ANDA approval (ANDA212247) for rivaroxaban, the Factor Xa inhibitor anticoagulant used to prevent stroke in atrial fibrillation and treat blood clots (DVT/PE), expanding generic access to this widely used drug.

BOSENTAN — MULTIPLE GENERIC SUPPLEMENTS APPROVED

  • Multiple supplemental ANDA approvals were issued for bosentan (an endothelin receptor antagonist for pulmonary arterial hypertension) to Natco Pharma, Zydus Pharma, Amneal Pharmaceuticals, Watson Labs, and Sun Pharma; the brand Tracleer (Actelion, NDA021290) also received a supplemental approval.
  • Bosentan blocks the endothelin pathway that causes abnormal blood vessel constriction in the lungs, and these generics broaden affordable access for PAH patients.

ALPELISIB (PIQRAY) SUPPLEMENT — NOVARTIS

  • Novartis received a supplemental approval for alpelisib (Piqray, NDA212526), a PI3K-alpha inhibitor; a Phase II trial (EPIK-P4, NCT06997588) is separately running to assess alpelisib in PIK3CA-related overgrowth spectrum (PROS) in pediatric and adult patients.

TRANEXAMIC ACID GENERIC — ZYDUS LIFESCIENCES

  • Zydus Lifesciences received an original ANDA approval (ANDA221213) for tranexamic acid, an antifibrinolytic agent used to control heavy bleeding in trauma, surgery, and heavy menstrual bleeding.

🧪 CLINICAL TRIALS

METFORMIN AS SENOLYTIC IN COPD (NCT07275359)

  • Sponsor and site not specified; this study tests metformin's ability to reduce aging blood biomarkers (senescence-associated secretory phenotype markers) in non-diabetic COPD patients alongside pulmonary rehabilitation.
  • Primary endpoints: safety, tolerability, and circulating senescence biomarker changes; currently recruiting as of November 3, 2026.

PET IMAGING IN THE BALTIMORE LONGITUDINAL STUDY OF AGING (NCT07099053)

  • Investigators are using amyloid and tau PET scans in aging cohort participants to build a longitudinal map of protein aggregation in the brain before symptoms emerge, a key strategy for early Alzheimer's intervention.

PSYCHOTROPIC MEDICATIONS AND FALL RISK IN OLDER ADULTS (NCT07112573)

  • Ain Shams University Geriatric Hospital (Egypt) is enrolling older adults discharged from geriatric care to assess whether psychotropic drug use correlates with increased falls and incident fractures — a major driver of disability and death in the elderly.

LUTETIUM-177 PSMA RADIOLIGAND THERAPY DOSING (RECIPROCAL TRIAL, NCT07200830)

  • This randomized Phase III trial tests whether adaptively lengthening the dosing interval of lutetium-177 Lu PSMA RLT in advanced prostate cancer preserves quality of life without reducing overall survival versus standard dosing.

SINGLE-LUNG VENTILATION AND COGNITIVE OUTCOMES IN GERIATRIC SURGERY (NCT07339124)

  • A trial is examining whether duration of one-lung ventilation during thoracic surgery and intraoperative brain oxygenation levels affect cognitive function and pain after surgery in older patients — directly relevant to post-operative cognitive decline risk in the elderly.

📢 PUBLIC HEALTH

LISTERIA — ONGOING OUTBREAK LINKED TO PREPARED MEALS

  • As of October 30, 2026, CDC continues urging consumers to check refrigerators and freezers for recalled prepared meal products after illnesses persisted despite recalls; the outbreak expanded in late September 2026 to include additional prepared food categories with 3 new illnesses and 1 additional death.

SALMONELLA — MORINGA LEAF SUPPLEMENTS

  • As of January 29, 2026, a total of 65 people in 28 states had been sickened in a Salmonella outbreak linked to moringa leaf dietary supplements; cases included extensively drug-resistant (XDR) Salmonella strains, with 3 hospitalizations.
  • A May 2026 CDC update flagged a growing number of Salmonella illnesses and outbreaks linked to moringa leaf products across multiple supplement brands.

RABIES — ELEVATED ANIMAL ACTIVITY IN U.S.

  • CDC issued a statement in September 2026 about a significant increase in animal rabies activity and associated human exposures across the United States, urging vigilance around wild and stray animals.

CANCER MORTALITY — LUNG CANCER PROGRESS

  • CDC's 2026 Annual Report to the Nation shows progress against lung cancer is driving down overall U.S. cancer mortality, though no specific numerical decline was provided in the summary.

ANTIMICROBIAL RESISTANCE WARNING

  • A September 2025 CDC report documented a sharp rise in dangerous drug-resistant bacteria in U.S. healthcare settings, reinforcing the urgency of antimicrobial stewardship alongside the ongoing BVD outbreak requiring antibiotic co-management.

This briefing is for informational purposes only. Nothing here constitutes medical advice. Consult a qualified healthcare provider for any health concerns.

BIOMED PULSE — Next edition: November 5, 2026.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  2. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  3. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  4. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  5. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  6. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  7. Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
  8. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  9. Middle East respiratory syndrome coronavirus - Kingdom of Saud… — WHO Disease Outbreak News
  10. Pneumonia of undetermined etiology - the Russian Federation — WHO Disease Outbreak News

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20261104-02-v126 · 2026-11-04 02:01 UTC · pulse.uzylab.com